SUANFARMA has donated 1,000 rapid anti-SARS-CoV-2 tests to the Alcobendas City Council for distribution in nursing homes in the municipality as well as for the care of its social services personnel.
Through this corporate social responsibility action, SUANFARMA wants to collaborate with the municipality where the headquarters are located and thus be able to help the most vulnerable people.
Francisco Fernández CEO of the SUANFARMA group has delivered the tests in a simple act to Ofelia Culebradas, Councilor for Health, and Inma Pullalto, Councilor for Social Services.
The rapid anti-SARS-CoV-2 test is an immunoassay intended for the detection and qualitative differentiation of SARS-CoV-2 IgG and IgM in anticoagulated human blood plasma (heparin / EDTA / sodium citrate) or serum of individuals with signs and symptoms of infection suspected of infection by COVID-19 by healthcare personnel. The Anti-SARS-CoV-2 Rapid Test is an aid to be used in the diagnosis of patients with suspected SARS-CoV-2 infection in conjunction with the clinical presentation and the results of other laboratory tests.
